{"name":"Mepha Ltd.","slug":"mepha-ltd","ticker":"","exchange":"","domain":"","description":"Mepha Ltd. is a pharmaceutical company based in Switzerland, focusing on the development and commercialization of generic and specialty drugs. The company has a portfolio of three key drugs, including formulations of esomeprazole and artesunate and mefloquine, which are in early stages of development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"artesunate and mefloquine","genericName":"artesunate and mefloquine","slug":"artesunate-and-mefloquine","indication":"Malaria caused by Plasmodium falciparum and other Plasmodium species","status":"marketed"}]}],"pipeline":[{"name":"artesunate and mefloquine","genericName":"artesunate and mefloquine","slug":"artesunate-and-mefloquine","phase":"marketed","mechanism":"Artesunate and mefloquine work synergistically to kill malaria parasites through distinct mechanisms: artesunate generates reactive oxygen species that damage parasite proteins and organelles, while mefloquine disrupts parasite digestive vacuole function and mitochondrial activity.","indications":["Malaria caused by Plasmodium falciparum and other Plasmodium species"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNUmJrNlFlR2VwYnhXZU9uM2d4OFRBYW1CcVFnazRucEwwcVhLVEpHMHA3VVlVdTRWVXplLUxsSmIxbmVQbVZpbjdZLUp5Zy1vRktzcW1mcUYtb21zYUN4bXBDM3d1QmxTbnQ0ZUJNQXFFUlBNRXZnOE5BeEpQS0Y0bzVFcmx2U2pQWmFCVnJ3MzFVcnc?oc=5","date":"2020-05-17","type":"pipeline","source":"Healthcare Digital","summary":"Mepha LLC merges with Acino Pharma - Healthcare Digital","headline":"Mepha LLC merges with Acino Pharma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}